CytoMed Therapeutics (GDTC) Notes Payables (2021 - 2025)
CytoMed Therapeutics (GDTC) posted Notes Payables of $31516.6 for Q4 2025, up 11.35% sequentially from $28304.4 in Q4 2024, and up 11.35% YoY from $28304.4 in Q4 2024.
CytoMed Therapeutics (GDTC) Notes Payables (2021 - 2025) Analysis & Trends
CytoMed Therapeutics has reported Notes Payables for 5 years, with the latest figure at $31516.6 in Q4 2025.
- Quarterly Notes Payables rose 11.35% year-over-year to $31516.6 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $31516.6 (up 11.35% YoY) and the FY2025 annual result came in at $31765.0, up 15.27% from the prior year.
- Notes Payables grew to $31516.6 in Q4 2025 per GDTC's latest filing, from $28304.4 in the prior quarter.
- Over five years, Notes Payables peaked at $284211.5 in Q4 2021 and troughed at $25128.7 in Q4 2023.
- A 5-year average of $122078.0 and a median of $31516.6 in 2025 frame the typical range for Notes Payables.
- The sharpest annual moves came in 2023 and 2024: Notes Payables plunged 89.58% in 2023, then advanced 12.64% in 2024.
- Over 5 years, Notes Payables stood at $284211.5 in 2021, then fell by 15.12% to $241229.0 in 2022, then slumped by 89.58% to $25128.7 in 2023, then increased by 12.64% to $28304.4 in 2024, then grew by 11.35% to $31516.6 in 2025.
- According to Business Quant data, Notes Payables over the past three periods registered $31516.6, $28304.4, and $25128.7 for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn |
| 4 | Moderna | 58.92 Bn | 53.78 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.70 Bn | 28.39 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.99 Bn | 9.60 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - |
| 10 | CytoMed Therapeutics | 9.97 Mn | 8.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 31,516.65 |
| Dec 31, 2024 | 28,304.38 |
| Dec 31, 2023 | 25,128.73 |
| Dec 31, 2022 | 241,229.01 |
| Dec 31, 2021 | 284,211.45 |